BioArctic AB (publ) (BRCTF)
USD 15.67
(0.0%)
USD 15.67
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 346.31 Million SEK | 124.93% |
| 2022 | 153.96 Million SEK | 582.33% |
| 2021 | -31.92 Million SEK | -363.7% |
| 2020 | 12.1 Million SEK | -94.22% |
| 2019 | 209.35 Million SEK | -63.18% |
| 2018 | 568.61 Million SEK | 637.84% |
| 2017 | 77.06 Million SEK | -26.87% |
| 2016 | 105.37 Million SEK | 153.47% |
| 2015 | 41.57 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 45.03 Million SEK | 64.34% |
| 2024 Q1 | 27.4 Million SEK | 153.57% |
| 2023 Q3 | 193.37 Million SEK | 1608.02% |
| 2023 Q4 | -51.15 Million SEK | -126.45% |
| 2023 Q2 | -12.82 Million SEK | -103.53% |
| 2023 Q1 | 363.28 Million SEK | 3114.6% |
| 2023 FY | 346.31 Million SEK | 124.93% |
| 2022 Q3 | 187.33 Million SEK | 1949.33% |
| 2022 FY | 153.96 Million SEK | 582.33% |
| 2022 Q4 | -12.05 Million SEK | -106.43% |
| 2022 Q2 | -10.13 Million SEK | 9.47% |
| 2022 Q1 | -11.19 Million SEK | 5.35% |
| 2021 FY | -31.92 Million SEK | -363.7% |
| 2021 Q2 | -6.04 Million SEK | -46.6% |
| 2021 Q3 | -9.93 Million SEK | -64.36% |
| 2021 Q4 | -11.82 Million SEK | -19.03% |
| 2021 Q1 | -4.12 Million SEK | 17.81% |
| 2020 Q1 | 25.94 Million SEK | 375.97% |
| 2020 Q4 | -5.01 Million SEK | -4260.87% |
| 2020 Q3 | -115 Thousand SEK | 98.68% |
| 2020 Q2 | -8.7 Million SEK | -133.57% |
| 2020 FY | 12.1 Million SEK | -94.22% |
| 2019 Q4 | 5.45 Million SEK | -23.69% |
| 2019 Q2 | 163.3 Million SEK | 388.21% |
| 2019 Q1 | 33.45 Million SEK | -92.84% |
| 2019 FY | 209.35 Million SEK | -63.18% |
| 2019 Q3 | 7.14 Million SEK | -95.63% |
| 2018 Q2 | 23.84 Million SEK | -8.86% |
| 2018 FY | 568.61 Million SEK | 637.84% |
| 2018 Q4 | 467.29 Million SEK | 810.77% |
| 2018 Q3 | 51.3 Million SEK | 115.13% |
| 2018 Q1 | 26.16 Million SEK | 9.32% |
| 2017 Q1 | 25.9 Million SEK | -72.5% |
| 2017 FY | 77.06 Million SEK | -26.87% |
| 2017 Q2 | 16.32 Million SEK | -36.98% |
| 2017 Q4 | 23.93 Million SEK | 27.14% |
| 2017 Q3 | 18.82 Million SEK | 15.31% |
| 2016 Q1 | 4.99 Million SEK | 0.0% |
| 2016 FY | 105.37 Million SEK | 153.47% |
| 2016 Q4 | 94.2 Million SEK | 7869.71% |
| 2016 Q3 | 1.18 Million SEK | 18.08% |
| 2016 Q2 | 1 Million SEK | -79.96% |
| 2015 FY | 41.57 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -2208.934% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -11164213.346% |
| SQZ Biotechnologies Company | 9.79 Million USD | -3436.012% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -2858.457% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -190.76% |
| Mesoblast Limited | -35.16 Million USD | 1084.75% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 1014205.417% |
| Genus plc | 178.7 Million USD | -93.798% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -84333.582% |
| Marizyme, Inc. | 457.7 Thousand USD | -75564.297% |
| ContraFect Corporation | -154 Thousand USD | 224981.169% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 3148436.364% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 692734.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -451062.7% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -526794.17% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 89471.898% |
| MultiCell Technologies, Inc. | 49.32 USD | -702183598.297% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -760.094% |
| EV Biologics, Inc. | 48.9 Thousand USD | -708114.724% |
| Q BioMed Inc. | -8988.00 USD | 3853204.139% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -1125.684% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 2245412.5% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | -57.342% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -494638.571% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 278823.712% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -556447.102% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 6993577.383% |
| Arch Therapeutics, Inc. | -2439.00 USD | 14199238.991% |
| IMV Inc. | -962.29 Thousand USD | 36088.54% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -246388.968% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 355242.286% |
| GB Sciences, Inc. | -624.00 USD | 55499619.231% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 402663.119% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 95.42% |
| Halberd Corporation | -208.00 USD | 166498657.692% |
| Enzolytics Inc. | 30.7 Thousand USD | -1127674.521% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -25418.092% |
| SYBLEU INC | 11.69 Thousand USD | -2960886.662% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -71685.512% |
| argenx SE | 1.1 Billion USD | 68.758% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 1442.418% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -55994.262% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 15.44% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 3910635.23% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -680.735% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 30436.851% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -34953.002% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -3503.34% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 413124.604% |
| BioStem Technologies, Inc. | 15.42 Million USD | -2145.189% |
| ONE Bio Corp. | 20.12 Million USD | -1620.792% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 2926310.393% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 717721.584% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -196046.919% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -196046.919% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 67410.062% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 55058.914% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 1194296.552% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -76851.98% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 108491.052% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -7415.56% |
| Bioxytran, Inc. | -8285.00 USD | 4180148.28% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 92946.381% |
| Neutra Corp. | 14.33 Thousand USD | -2415784.2% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 422437.805% |
| PureTech Health plc | -1.6 Million USD | 21704.304% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 34688.948% |
| IXICO plc | 3.27 Million USD | -10490.734% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 50001.585% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 19436.516% |
| CSL Limited | 7.7 Billion USD | 95.505% |
| Cellectis S.A. | 18 Thousand USD | -1923883.333% |